Araris Biotech
PDF) Linkers Having a Crucial Role in Antibody–Drug Conjugates
ADC Pharmacokinetics Characterization - Creative Biolabs
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
PDF) Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation - ScienceDirect
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
Antibody–Drug Conjugates: Perspectives and Characterization | Chromatography Online
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
Antibody–drug conjugates | Nature Reviews Drug Discovery
Frontiers | The Analysis of Key Factors Related to ADCs Structural Design | Pharmacology
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade | HTML
Antibody-drug conjugate - Wikipedia
ANTIBODY DRUG CONJUGATES - ADC Development Using SMARTag(TM) Technology
How Far We Have Advanced in the Chemotherapy World - IBL America Online Store
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates | SpringerLink
Antibody–Drug Conjugates: Perspectives and Characterization | Chromatography Online
